相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Co-delivery of 5-fluorouracil and oxaliplatin in novel poly (3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly (lactic-co-glycolic acid) nanoparticles for colon cancer therapy
Somayeh Handali et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma
Chen Zhong et al.
PHYTOMEDICINE (2019)
Systemic treatment of pancreatic cancer revisited
Michel Ducreux et al.
SEMINARS IN ONCOLOGY (2019)
Evaluation of Angiogenesis Assays
Zachary I. Stryker et al.
BIOMEDICINES (2019)
In vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system
Ali Hafez Ali Mohammed El-Far et al.
ONCOLOGY LETTERS (2018)
3,3′-Diindolylmethane suppresses ovarian cancer cell viability and metastasis and enhances chemotherapy sensitivity via STAT3 and Akt signaling in vitro and in vivo
Minghua Zou et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Inhibitory effects of 3,3′-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer
Geum-A Lee et al.
FOOD AND CHEMICAL TOXICOLOGY (2017)
CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line
Ahmed A. Abd-Rabou et al.
ADVANCES IN MEDICAL SCIENCES (2017)
The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer
Jingna Su et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Nanoformulations for combination or cascade anticancer therapy
Lei Miao et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
3,3′-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy
Yang Ye et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention
Amit B. Shirode et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Aamir Ahmad et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Synthesis, characterization and anti-tumor activity of novel thymoquinone analogs against pancreatic cancer
Mujahid Yusufi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Nanoformulation of natural products for prevention and therapy of prostate cancer
Vanna Sanna et al.
CANCER LETTERS (2013)
Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice
Min Zhao et al.
CANCER LETTERS (2013)
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats
Najeh Maissar Khalil et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage
Amit Kumar Srivastava et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Hongkee Sah et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
3,3′-Diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells
Holly L. Nicastro et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Resveratrol-Loaded Nanoparticles Based on Poly(epsilon-caprolactone) and Poly(D,L-lactic-co-glycolic acid)-Poly(ethylene glycol) Blend for Prostate Cancer Treatment
Vanna Sanna et al.
MOLECULAR PHARMACEUTICS (2013)
Sulforaphane: translational research from laboratory bench to clinic
Christine A. Houghton et al.
NUTRITION REVIEWS (2013)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: Comparison with other cancer preventive phytochemicals
Thomas T. Y. Wang et al.
MOLECULAR CARCINOGENESIS (2012)
Blocking Epidermal Growth Factor Receptor Activation by 3,3′-Diindolylmethane Suppresses Ovarian Tumor Growth In Vitro and In Vivo
Prabodh K. Kandala et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis
Gaurav Kumar et al.
DRUG DELIVERY (2011)
PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms
Xiaoxia Xie et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Influence of ellagic acid on prostate cancer cell proliferation: A caspase-dependent pathway
Arshi Malik et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2011)
Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects
Dhruba J. Bharali et al.
Cancers (2011)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise
Dhruba J. Bharali et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate
Imtiaz A. Siddiqui et al.
CANCER RESEARCH (2009)
Current advances in research and clinical applications of PLGA-based nanotechnology
Jian-Ming Lue et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats
D. R. Kalaria et al.
PHARMACEUTICAL RESEARCH (2009)
Concept and clinical evaluation of carrier-mediated anticancer agents
William C. Zamboni
ONCOLOGIST (2008)
Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats
K. Sonaje et al.
PHARMACEUTICAL RESEARCH (2007)
Improved bioavailability of orally administered mifepristone from PLGA nanoparticles
Weiling He et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours
Navindra P. Seeram et al.
JOURNAL OF NUTRITION (2006)
Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans:: Identification of biomarkers and individual variability
B Cerdá et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans
B Cerdá et al.
EUROPEAN JOURNAL OF NUTRITION (2004)
Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice
NP Seeram et al.
CLINICA CHIMICA ACTA (2004)
Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid - extensive binding to protein and DNA
AC Whitley et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Cross-linked polyvinylpyrrolidone nanoparticles: a potential carrier for hydrophilic drugs
DJ Bharali et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2003)
分享论文
